East Lancashire Hospitals NHS Trust orders Ascribe's ePrescribing and Business Change Consultancy

AscribeAscribe announced the order of their electronic Prescribing and Medicines Administration (ePMA) solution by East Lancashire Hospitals NHS Trust ("East Lancashire"), together with Business Change Consultancy services to assist with associated cultural, IT and process changes designed to improve patient safety and increase operational performance.

The project was supported by the Primary Care Trust's Clinical Commissioning Group as the Ascribe solution will deliver closer integration between primary and secondary care providers and thereby improve patient safety. The solution enables Trust staff to make more informed care decisions when prescribing patients' medications through a secure link to their General Practitioner (GP) held medication records. In addition to this, better quality patient care information will also flow back to patients' GPs through Ascribe's integrated eDischarge Summary, these contain a more richly detailed record of Trust prescribed medication and provide improved quality of continuing care that is essential to GP care management and delivery.

The order marks the latest phase of the Trust's strategic partnership with Ascribe to implement a fully integrated Pharmacy solution. The Trust is one of Ascribe's longest standing customers, having safely used Ascribe Pharmacy departmental systems for over 20 years. Other Ascribe solutions used by East Lancashire include:

  • Web Pharmacy
  • eMedicines Management
  • E-MAT (Medical Equipment Management and Traceability System)

With two major parts of an integrated pharmacy solution already in place (Web Pharmacy and eMedicines Management), ePMA is the final component which will enable a 'single workflow of information' from the prescriber to the dispensary staff, using a single patient record which eliminates the need to transcribe routine medications, and provides decision support to clinicians.

The introduction of ePMA to East Lancashire, a large multi-site trust, will have significant impact on the Trust's clinical processes and staff. As part of this solution, Ascribe will initially provide its business and clinical change consultancy expertise to assist the Trust with agreeing new best practice clinical processes that will be enabled by the ePMA solution. East Lancashire is the first Trust to include Business Change Consultancy services, since Ascribe’s announcement in March 2012 of this new consultancy offering.

Neil Fletcher, Clinical Director of Pharmacy at East Lancashire, commented on the project "The entire Trust will benefit from the ePMA solution by having more integrated systems and improving patient care."

Jonathan Wood, Director of Finance at East Lancashire, commented "With enhanced clinical processes that ePMA will put in place for the Trust, the cost associated with non-value adding activity, such as manual transcription, will be saved by the Trust."

Stephen Critchlow, CEO at Ascribe, commented "We are pleased with that East Lancashire has chosen Ascribe for their electronic prescribing solution. It is a great feeling for the team when our first customer continues to build on a solution which will benefit their carers and staff."

About Ascribe ePMA
Ascribe electronic Prescribing and Medicines Administration (ePMA) provides the closed loop of medicines management leading to tighter control of drug budgets, faster discharge turnaround and increased safety.

ePMA enables complex regimens to be prescribed with a single click and supports all forms of UK practice - Independent prescribing, Supplementary prescribing and Patient Group directions. Drug supply requests are instantly communicated for faster turnaround. The prescriptions are coded in such a way that they pass seamlessly to robotic dispensing and manufacturing.

The solution is designed to follow the workflow of clinicians and nurses for prescribing and administration. The system has in-built Medicines Reconciliation and supports clinical screening by pharmacists. The use of Patient's own medication is supported and drug administration can be recorded via touchscreen devices. ePMA provides an end-to-end integrated process with no transcription.

About East Lancashire Hospitals NHS Trust
East Lancashire Hospitals NHS Trust provides high quality services for the local population of over half a million people across East Lancashire and the surrounding area. The Trust employs 7,000 staff, many of whom are internationally renowned and have won awards for their work, and treats nearly three quarters of a million patients a year from the most serious of emergencies to planned operations and procedures.

East Lancashire Hospitals NHS Trust was formed on the 1st April 2003, following the merger of Blackburn Hyndburn and Ribble Valley Health Care NHS Trust and Burnley Health Care NHS Trust.

About Ascribe
From trust-wide EPR solutions through to individual departmental clinical systems and services, Ascribe is able to deliver IT solutions that cater to all secondary care clinical requirements. Using a professional Consultancy division, Ascribe also delivers a comprehensive range of Integration and Business Intelligence solutions based on Microsoft® & other third party IT suppliers to significantly improve clinical and operational efficiencies, to improve patient safety and reduce operating costs.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...